Suchergebnisse - "Liu, Jiacheng"

PubPharm (8)

1

Nanoscale CaO2 materials for synergistic transarterial chemoembolization in a VX2 orthotopic rabbit liver cancer model

enthalten in: Acta biomaterialia | 2022

von Wang, Y. | He, X. | Zhou, C. | +7

2

Comparison of DEB-TACE and cTACE for the initial treatment of unresectable hepatocellular carcinoma beyond up-to-seven criteria : A single-center propensity score matching analysis

enthalten in: Clinics and research in hepatology and gastroenterology | 2022

von Shi, Q. | Liu, J. | Li, T. | +6

3

Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination

enthalten in: BMC cancer | 2022

von Ju, S. | Zhou, C. | Hu, J. | +10

4

Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination

enthalten in: BMC cancer | 2022

von Ju, S. | Zhou, C. | Hu, J. | +10

5

Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination

enthalten in: BMC cancer | 2022

von Ju, S. | Zhou, C. | Hu, J. | +10

6

Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size : results of a single-center retrospective case control study

enthalten in: BMC cancer | 2019

von Ren, Y. | Cao, Y. | Ma, H. | +7

7

Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study

enthalten in: BMC cancer | 2019

von Ren, Y. | Cao, Y. | Ma, H. | +7

8

Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study

enthalten in: BMC cancer | 2019

von Ren, Y. | Cao, Y. | Ma, H. | +7

1
[1]